Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative ColitisMamoru Watanabe,Satoshi Motoya,Kenji Watanabe,Haruhiko Ogata,Takanori Kanai,Toshiyuki Matsui,Yasuo Suzuki,Mitsuhiro Shikamura, Masataka Igeta,Kazunori Oda,Tetsuharu Hori,Takahiro Araki,Toshifumi HibiGastroenterology（2018）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
